| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8659695 | Heart, Lung and Circulation | 2018 | 6 Pages |
Abstract
In our institution, the use of NOACs in electrical cardioversion increased significantly over the study period and in our experience, they appear to be as safe as warfarin with low rates of ischaemic stroke and major bleeding. In addition, a short duration NOAC strategy was comparable to longer duration therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Giuseppe BSc, MBBS, Taufik MBBS, FRACP, Pratap MD, FCSANZ, Astin MBBS, FCSANZ,